Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops algorithms and business solutions to large-data problems.
Year Established: | 2008 |
Funding: | |
Address: | Cambridge, MA 02139 |
Telephone: | |
Mobile: | |
Fax: | |
Mail: | info@FinaTechnologies.com |
Company URL: | http://www.finatechnologies.com |
An article in Xconomy Boston profiles how Fina is using REFSTM technologies to build the next generation of market-predicting financial models.
Fina Technologies Inc. today announced that it has completed a $4.5 million Series A financing which includes a lead investment by Reed Elsevier Ventures the venture capital arm of the multibillion dollar Anglo-Dutch media conglomerate Reed Elsevier owner of such assets as Lexis-Nexis and an investment from the venture capital firm Excel Venture Management.
An article by CEO Josh Holden featured in Forbes Magazines The AI Report discusses the challenges human variables in markets pose to artificial intelligence prediction models.
Gene Network Sciences the company that launched Fina Technologies is awarded a patent on the REFSTM platform. Fina uses the REFSTM platform to tackle big-data problems in ecommerce and quantitative finance.
Fina Technologies Inc. today announced that it named Dr. Christopher Ahlberg a pioneering entrepreneur and scientist and founder of Spotfire Inc. to its Board of Directors.
Fina Technologies was featured today in an article in Forbes detailing the emerging class of "Big Data" problems that are Fina Technologies core competency.
Fina is launched from GNS to apply REFSTM technology to tackle "big data" problems in quantitative finance and ecommerce.
Phone: (617) 494-0492
Cambridge MA
Email info@FinaTechnologies.com
The requested document was not found on this server.
Â
Web Server at finatechnology.comExcel Venture Management,Reed Elsevier Ventures
Joshua Holden
President & Chief Executive Officer
Dave DeCaprio
Chief Technology Officer
Dave has a broad range of experience in technology leadership and management at successful startups. Prior to joining Fina, he helped establish the chemical biology platform at the Broad Institute, which grew in three years to over 100 people and secured over $100 million in funding. Previously, Dave was chief architect at ITLS, which was purchased by i2 Technologies for $100 million in 1997. He was also the first software developer for eRoom, a highly successful groupware product purchased by Documentum and still sold by EMC. He graduated MIT in 1993 with a BS in Electrical Engineering and Computer Science, and has published peer reviewed articles on machine learning, computational biology, and cheminformatics.
Board of Directors
BACK TO TOP
Colin Hill (Chairman)
President & CEO, Gene Network Sciences, Inc.
Colin Hill brings years of hands-on scientific experience to his role, with expertise in the areas of computational physics and systems biology. Hill is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and the Economist. He also serves on the board of directors of the New York Foundation for Science, Technology and Innovation (NYSTAR) and as a board member of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease. In 2004, Hill was named to MIT Technology Review's TR100 list of the top innovators in the world under the age of 35. He graduated from Virginia Tech with a degree in physics and earned master's degrees in physics from McGill University and Cornell University.
BACK TO TOP
Christopher Ahlberg, Ph. D.
Founder, Spotfire, Inc.
Dr. Christopher Ahlberg most previously was Executive Vice President, Tibco, Inc., and President of Tibco's Spotfire division, dating back to 2007. Prior to TIBCO, Dr. Ahlberg was the founder and CEO of Spotfire, Inc., a provider of enterprise analytics software for next generation business intelligence and scientific applications. Dr. Ahlberg was named among the World's Top Young Innovators by Technology Review, MIT's Magazine of Innovation, in 2002. Dr. Ahlberg earned his doctorate from Chalmers University of Technology, has worked as a visiting researcher at the University of Maryland, and has lectured and consulted extensively for industry, academia, and the military - as well as having published and lectured in computer science, psychology, linguistics, biology, and chemistry.
BACK TO TOP
Kevin Brown
Partner, Reed Elsevier Ventures
Reed Elsevier Ventures is responsible for making investments in innovative late-stage companies that have the potential to provide the Reed Elsevier Group with new technologies, products, services or customers. Kevin was one of Reed Elsevier Ventures' founding partners in late 2000, joining from SOFTBANK/News Corporation's European joint venture fund, eVentures. Prior to that he was an entrepreneur, having founded a risk management technology company selling derivative pricing and management software to the banking and energy industries. Previously, Kevin had spent a number of years at Arthur Andersen's European strategy consulting practice where he specialised in helping many of the world's largest energy and utilities companies formulate merger and acquisition and growth strategies, helping them seek opportunities in markets that were being liberalized. Whilst at Reed Elsevier Ventures Kevin has overseen a number of important deals including iPhrase (acquired by IBM), Babylon (TASE: BBYL), Intraspect (acquired by Vignette), SRD (acquired by IBM), Inxight (acquired by Business Objects) and AllBusiness. He is currently active on the boards of Healthline, Jobster and Palantir. Kevin has a Master Of Arts degree in Social and Political Sciences from King’s College, Cambridge.
BACK TO TOP
Robert Maroney
Investment Manager, Connecticut Investments, LLC.
Robert Maroney oversees all activities of a multi-entity family office and invests broadly in virtually every asset class. The individual entities vary considerably by size, risk profile and cash flow requirements. A large proportion of the assets are in alternative assets, including single-manager funds and private equity, along with a more modest allocation to venture capital. With over 40 hedge funds across all entities, the portfolio investments are constructed to meet the profile of each individual account. Prior to work as and investment professional, Maroney served as a division president of a multinational Fortune 200 firm and was the CEO of a privately owned global manufacturing company. He holds a BS in electrical engineering from Cornell University and an MBA with high distinction from the Harvard Business School, where he was a Baker Scholar.
BACK TO TOP
Bill Trenchard
Board of Directors, LiveOps
With over a dozen years of experience as an Internet entrepreneur, Bill offers an expert perspective in his role as a Fina Technologies board member. Previously, Bill was CEO of LiveOps from January 2004 until December 2006 and was co-founder and CEO of CallCast, a revolutionary call routing technology firm that merged with LiveOps in 2003. Bill is currently a board member of LiveOps. Prior to CallCast, Bill was a managing director at idealab!, where he served portfolio companies in capacities ranging from a board member to interim CEO. Bill also founded and served as CEO of Jump Networks, Inc., which was acquired by Microsoft Corporation in April 1999. Bill has a Bachelor of Arts degree in science and technology studies from Cornell University.